Effect of dilution on high-density lipoprotein associated paraoxonase-1 activity

被引:4
|
作者
Mackness, Mike [1 ]
Mackness, Bharti [1 ]
机构
[1] PONTECH ART, Tarragona 43840, Spain
关键词
Paraoxonase-1; HDL; Activity assays;
D O I
10.1016/j.clinbiochem.2011.08.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To investigate the effects of dilution on high-density lipoprotein (HDL) associated paraoxonase-1 (PON1) activity. Design and methods: HDL was prepared by ultracentrifugation, diluted with TRIS buffer pH 8.2 (0-128 fold) and assayed spectrophotometrically for PON1 activity using paraoxon and phenyl acetate. Results: HDL-PON1 activity increased progressively with dilution to over 200% of the undiluted activity by 128 fold dilution (P<0.001). Conversely HDL size decreased. Conclusion: These results indicate the urgent need to standardise conditions for measuring PON1 activity. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1270 / 1271
页数:2
相关论文
共 50 条
  • [1] Dysfunctional High-density Lipoprotein: The Role of Myeloperoxidase and Paraoxonase-1
    Bacchetti, Tiziana
    Ferretti, Gianna
    Carbone, Federico
    Ministrini, Stefano
    Montecucco, Fabrizio
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (14) : 2842 - 2850
  • [2] Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
    Judit Marsillach
    Gerard Aragonès
    Bharti Mackness
    Michael Mackness
    Anna Rull
    Raúl Beltrán-Debón
    Juan Pedro-Botet
    Carlos Alonso-Villaverde
    Jorge Joven
    Jordi Camps
    Lipids in Health and Disease, 9
  • [3] Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
    Marsillach, Judit
    Aragones, Gerard
    Mackness, Bharti
    Mackness, Michael
    Rull, Anna
    Beltran-Debon, Raul
    Pedro-Botet, Juan
    Alonso-Villaverde, Carlos
    Joven, Jorge
    Camps, Jordi
    LIPIDS IN HEALTH AND DISEASE, 2010, 9
  • [4] High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure
    Hammadah, Muhammad
    Kalogeropoulos, Andreas P.
    Georgiopoulou, Vasiliki V.
    Weber, Malory
    Wu, Yuping
    Hazen, Stanley L.
    Butler, Javed
    Tang, W. H. Wilson
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (06) : 748 - 755
  • [5] Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
    Beekhof, Piet K.
    Gorshunska, Maryana
    Jansen, Eugene H. J. M.
    LIPIDS IN HEALTH AND DISEASE, 2012, 11
  • [6] Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
    Piet K Beekhof
    Maryana Gorshunska
    Eugène HJM Jansen
    Lipids in Health and Disease, 11
  • [7] Impaired High-density Lipoprotein Antioxidant Activity and Serum Paraoxonase-1 Activity in Type II Diabetic Patients
    Mingpakanee, Raveenan
    Charoensa, Natchon
    Phrawisat, Yoknapa
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (05) : BC13 - BC17
  • [8] Nitrite Prevents Myeloperoxidase-Mediated Loss of Paraoxonase-1 Activity From High-Density Lipoprotein
    Weber, Robyn L.
    Lynch, Sean M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 : S44 - S45
  • [9] Alterations in lipid transfer to high-density lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients
    Daminelli, Elaine Nunes
    Spada, Celso
    Treitinger, Aricio
    Oliveira, Tatiane Vanessa
    Latrilha, Maria da Conceicao
    Maranhao, Raul Cavalcante
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2008, 50 (04): : 223 - 227
  • [10] The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity
    James, RW
    Deakin, SP
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (12) : 1986 - 1994